AstraZenecas extended-release metoprolol (Toprol-XL) ran for years after the base metoprolol patents expired, protected by formulation patents and backed by clinical data showing improved tolerability
Moreover, IGF-1 boosts bone healing and increases movement in patients with tibia and hip fractures [2]
To summarize the last article: GLP-1 medications are reshaping modern medicine because they target the gut-brain-metabolic axis that drives most chronic disease - not just weight loss, but cardiovascular disease, heart failure, kidney disease, neurodegeneration, fatty liver, and systemic inflammation
These improvements are likely to increase patient compliance and improve their overall quality of life
Several small observational studies have documented improvements in IBS-related symptoms among patients using semaglutide, including reduced bloating, decreased constipation episodes, and lower abdominal pain scores